Stem cells – what is the evidence: Currently licensed products in the UK: DogStem
DogStem
Published 26 February 2024
Dogstem suspension for injection into dogs contains equine umbilical cord mesenchymal stem cell and is indicated for “Improvement in function, reduction of pain and lameness associated with mild to severe osteoarthritis in hip and elbow joints”.
Veterinary Medicines Directorate (2022) Summary of Product Characteristics: DogStem suspension for injection for dogs. Available from: https://www.vmd.defra.gov.uk/ProductInformationDatabase/files/SPC_Documents/SPC_2396489.PDF [Accessed 26 February 2024]
- Punzón, E. et al. (2022) Equine umbilical cord mesenchymal stem cells demonstrate safety and efficacy in the treatment of canine osteoarthritis: a randomized placebo-controlled trial. Journal of the American Veterinary Medical Association, 260 (15), pp. 1947-1955. https://doi.org/10.2460/javma.22.06.0237
- Punzón, E. et al. (2023) Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: a randomized controlled trial. Frontiers in Veterinary Science, 10, no. 1098029. https://doi.org/10.3389/fvets.2023.1098029
Claiming CPD for reading inFOCUS articles
Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process.
Online full-text available to Library members
A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.
Leave a Reply
Want to join the discussion?Feel free to contribute!